Name | L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid |
Synonyms | (S)-TIC L-Tic-OH L-1,2,3,4-Tetrahydro 4-Tetrahydro-3-Isoquinolinecarboxylic acid L-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic acid S-1,2,3,4-Tetrahydro-isoquinoline-3-carboxylic acid [S]-1,2,3,4-Tetrahydro-3-Isoquinolingcarboxylic Acid (S)-1,2,3,4-Tetrahydro-3-isoquinoline-carboxylic acid (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid (S)-N-tert-1,2,3,4-tetrahydroisoquinoline -3-carboxamide (S)-(-)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid (S)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXYLIC ACID METHYLESTHER (S)-1, 2, 3, 4-tetrahydro-3-isoquinolinecarboxylic acid (for Quinapril) |
CAS | 74163-81-8 |
EINECS | 616-058-0 |
InChI | InChI=1/C10H11NO2.ClH/c12-10(13)9-5-7-3-1-2-4-8(7)6-11-9;/h1-4,9,11H,5-6H2,(H,12,13);1H/t9-;/m0./s1 |
InChIKey | BWKMGYQJPOAASG-VIFPVBQESA-N |
Molecular Formula | C10H11NO2 |
Molar Mass | 177.2 |
Density | 1.1607 (rough estimate) |
Melting Point | >300°C(lit.) |
Boling Point | 309.12°C (rough estimate) |
Specific Rotation(α) | -157.4 º (24 ºC) |
Flash Point | 193.2°C |
Vapor Presure | 5.62E-07mmHg at 25°C |
Appearance | White to Light Yellow Crystal |
Color | White to Almost white |
BRN | 4842199 |
pKa | 2.21±0.20(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,2-8°C |
Refractive Index | -166 ° (C=1, 1mol/L |
MDL | MFCD00144533 |
Use | Used as a drug Intermediate |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S37/39 - Wear suitable gloves and eye/face protection |
WGK Germany | 3 |
HS Code | 29334900 |
Introduction | (S)-(-)-1,2,3, 4-tetrahydroisoquinoline-3-carboxylic acid is a quinoline derivative and is used as an intermediate for the synthesis of quinapril. Quinapril is a product developed by Pfizer and approved by the US FDA in 1991 for hypertension, congestive heart failure and angioedema. |
Use | for use as a pharmaceutical intermediate Quinapril intermediate. |